Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia.
Duault C, Kumar A, Taghi Khani A, Lee SJ, Yang L, Huang M, Hurtz C, Manning B, Ghoda L, McDonald T, Lacayo NJ, Sakamoto KM, Carroll M, Tasian SK, Marcucci G, Yu J, Caligiuri MA, Maecker HT, Swaminathan S.
Duault C, et al. Among authors: marcucci g.
Blood. 2021 Oct 21;138(16):1465-1480. doi: 10.1182/blood.2020009871.
Blood. 2021.
PMID: 34077953
Free PMC article.